Popular Articles

Largest Lupus Drug Trial Ever Completed Is Successful!
Today, Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) announced positive results from a year-long clinical trial of BENLYSTA for treating lupus. When the 52-week study concluded, the lupus patients who were treated with BENLYSTA had improvement in overall disease activity without clinically significant flare-ups in one or more isolated organs when compared to patients who received the placebo (inactive agent). The patients receiving BENLYSTA also were able to reduce their intake of steroid medications. The study is the largest ever to be completed for lupus and the first Phase III (late stage) trial of a new biologic immune therapy for lupus to succeed in meeting its primary endpoint and most of its secondary endpoints.
drugs without prescription
Confirmation Hearings For Supreme Court Nominee Sotomayor To Begin July 13
Senate Democrats on Tuesday announced that confirmation hearings for Judge Sonia Sotomayor"s nomination to the Supreme Court are set to begin on July 13, the New York Times reports. According to Democrats, the schedule puts the Senate on track to confirm Sotomayor before the August recess. By the Thursday before the recess, 72 days will have elapsed since President Obama nominated Sotomayor, which is the same number of days that passed during the confirmation process for Chief Justice John Roberts (Herszenhorn, New York Times, 6/10).Senate Judiciary Committee Chair Patrick Leahy (D-Vt.) said, "There is no reason to unduly delay consideration of this well-qualified nominee." He said that critics" attacks on her character are "compelling reasons to proceed even ahead of this schedule," adding that Sotomayor needs to be given a chance to respond to her critics (Isenstadt/Raju, Politico, 6/9).Republican senators have started a campaign to stall the confirmation process, saying they need more time to review her judicial record (LoBianco, Washington Times, 6/10). Republican senators had requested to delay the hearing until September. Senate Minority Leader Mitch McConnell (R-Ky.) said that Democrats are acting "unilaterally" and "being dismissive of the minority"s legitimate concerns for a fair and thorough process."Senate Majority Leader Harry Reid (D-Nev.) said he discussed the timeline with Obama and Leahy, both of whom had reviewed a letter from McConnell that expressed concerns about the process starting before September. According to Reid, Obama and Leahy went ahead with an earlier schedule after concluding that the timetable was similar to that of past nominations (New York Times, 6/10).
News of the day
MitraClip(R) Therapy Data Demonstrate Clinical Benefit In High-Risk Patients With Mitral Regurgitation
Results show percutaneous mitral repair using the MitraClip(R) system in symptomatic high-risk surgical patients with either functional mitral regurgitation (FMR) or degenerative mitral regurgitation (DMR) improves patient clinical status. The results from the 78 patient EVEREST II High Risk Registry demonstrated improvement in left ventricular function and reduced hospitalization for congestive heart failure for both MR groups at twelve months. Additionally, a reduction in mortality compared to the predicted mortality risk of surgery was reported for the registry. The results of the High-Risk Registry were presented at the third annual meeting of EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Mental Health

New Online Tool Maps HIV, AIDS Prevalence By County, Other Statistics

The National Minority Quality Forum (NMQF) today launched an online tool that maps the prevalence of HIV and AIDS by county, age, gender and ethnicity in all 50 states, Washington, D.C., Puerto Rico and the U.S. Virgin Islands, the San Francisco Chronicle reports. The HIV/AIDS Atlas is based on 2006 data collected from states and cross-checked with CDC data. The NMQF partnered with George Washington University"s School of Public Health and Health Services to collect and analyze the data. Gary Puckrein, chief executive officer of NMQF, said the new tool will help improve data collection and analysis, prevention initiatives, early diagnosis and routine testing efforts in areas most affected by HIV/AIDS (Colliver, San Francisco Chronicle, 6/21). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):